ReviewMolecular medicine (Cambridge, Mass.)2020

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

Ulf Andersson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.